Oxford Cryotechnology
Oxford Cryotechnology is a UK-based company specializing in AI-guided design to develop advanced cryopreservation methods for biomedical applications. Their technology focuses on improving vitrification protocols to preserve cells, tissues, and organs at low temperatures, aiming to enable long-term storage with minimal toxicity and loss of viability. The company leverages computational and machine learning techniques combined with in vitro experiments to optimize cryoprotectant formulations and protocols. Their work addresses critical challenges in biobanking, organ transplantation, tissue engineering, and regenerative medicine, with potential future applications in human cryonics. The company is led by experienced researchers with strong academic and industry backgrounds and collaborates with experts in cryobiology and aging research. Oxford Cryotechnology targets the multi-billion dollar cryopreservation market, aiming to reduce organ wastage and support personalized tissue engineering through improved vitrification technology.
Oxford Cryotechnology
Oxford Cryotechnology is a UK-based company specializing in AI-guided design to develop advanced cryopreservation methods for biomedical applications. Their technology focuses on improving vitrification protocols to preserve cells, tissues, and organs at low temperatures, aiming to enable long-term storage with minimal toxicity and loss of viability. The company leverages computational and machine learning techniques combined with in vitro experiments to optimize cryoprotectant formulations and protocols. Their work addresses critical challenges in biobanking, organ transplantation, tissue engineering, and regenerative medicine, with potential future applications in human cryonics. The company is led by experienced researchers with strong academic and industry backgrounds and collaborates with experts in cryobiology and aging research. Oxford Cryotechnology targets the multi-billion dollar cryopreservation market, aiming to reduce organ wastage and support personalized tissue engineering through improved vitrification technology.